Bank Of America Corp Dice Therapeutics, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $1.86 Million - $3.36 Million	71,984 Added 103.79%	141,340 $6.57 Million
Q1 2023 May 12, 2023	BUY	$26.05 - $32.31 $1.02 Million - $1.27 Million	39,278 Added 130.59%	69,356 $1.99 Million
Q4 2022 Feb 10, 2023	BUY	$19.77 - $42.23 $269,089 - $574,792	13,611 Added 82.66%	30,078 $938,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $63,936 - $96,738	4,271 Added 35.02%	16,467 $333,000
Q2 2022 Aug 12, 2022	SELL	$13.19 - $22.1 $2,994 - $5,016	-227 Reduced 1.83%	12,196 $189,000
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $1.24 Million - $2.14 Million	-85,405 Reduced 87.3%	12,423 $237,000
Q4 2021 Feb 08, 2022	BUY	$22.41 - $37.54 $2.17 Million - $3.63 Million	96,650 Added 8204.58%	97,828 $2.48 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $37,601 - $43,586	1,178 New	1,178 $38,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.